ANL 28.45 Decreased By ▼ -1.10 (-3.72%)
ASC 19.69 Decreased By ▼ -0.29 (-1.45%)
ASL 24.45 Increased By ▲ 0.05 (0.2%)
BOP 8.17 Decreased By ▼ -0.09 (-1.09%)
BYCO 9.80 Decreased By ▼ -0.24 (-2.39%)
FCCL 21.88 Decreased By ▼ -0.07 (-0.32%)
FFBL 26.60 Decreased By ▼ -0.40 (-1.48%)
FFL 20.05 Increased By ▲ 0.72 (3.72%)
FNEL 8.39 Decreased By ▼ -0.03 (-0.36%)
GGGL 24.90 Decreased By ▼ -0.26 (-1.03%)
GGL 41.69 Decreased By ▼ -1.91 (-4.38%)
HUMNL 6.81 Decreased By ▼ -0.11 (-1.59%)
JSCL 20.60 Decreased By ▼ -0.90 (-4.19%)
KAPCO 39.00 No Change ▼ 0.00 (0%)
KEL 3.82 Decreased By ▼ -0.01 (-0.26%)
MDTL 3.39 Decreased By ▼ -0.13 (-3.69%)
MLCF 43.05 Decreased By ▼ -0.45 (-1.03%)
NETSOL 149.30 Decreased By ▼ -7.70 (-4.9%)
PACE 7.12 Decreased By ▼ -0.08 (-1.11%)
PAEL 32.05 Decreased By ▼ -1.23 (-3.7%)
PIBTL 10.86 Decreased By ▼ -0.09 (-0.82%)
POWER 8.95 Decreased By ▼ -0.11 (-1.21%)
PRL 22.80 Decreased By ▼ -0.30 (-1.3%)
PTC 11.66 Decreased By ▼ -0.22 (-1.85%)
SILK 1.77 Increased By ▲ 0.05 (2.91%)
SNGP 49.70 Decreased By ▼ -1.04 (-2.05%)
TELE 15.50 Increased By ▲ 0.33 (2.18%)
TRG 154.43 Decreased By ▼ -5.82 (-3.63%)
UNITY 40.00 Decreased By ▼ -0.55 (-1.36%)
WTL 3.47 Increased By ▲ 0.04 (1.17%)
BR100 5,043 Decreased By ▼ -50.24 (-0.99%)
BR30 25,215 Decreased By ▼ -494.66 (-1.92%)
KSE100 47,055 Decreased By ▼ -257.04 (-0.54%)
KSE30 18,837 Decreased By ▼ -126.39 (-0.67%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,422
6224hr
Pakistan Cases
1,034,837
5,02624hr
8.82% positivity
Sindh
382,865
Punjab
356,920
Balochistan
30,432
Islamabad
87,699
KPK
144,264

Abbott Laboratories

Abbott cuts 2021 profit forecast on lower COVID-19 testing demand

Abbott cuts 2021 profit forecast on lower COVID-19 testing demand

  • "This has been driven by several factors, including significant reductions in cases in the US and other major developed countries, accelerated rollout of COVID-19 vaccines globally and, most recently, US health authority guidance on testing for fully vaccinated individuals," the drugmaker said.
  • Abbott sees second-quarter adjusted profit from continuing operations of at least $1 per share, compared with analysts' estimates of $1.23 per share.
Published 01 Jun, 2021 06:51pm
Abbott first-quarter profit surges on COVID-19 test demand
Business & Finance

Abbott first-quarter profit surges on COVID-19 test demand

  • A recovery in medical device sales as vaccinations encourage patients to opt for elective surgeries put off during the pandemic is now energizing the companies' top line.
  • In the latest quarter, Abbott's COVID-19 test kits generated sales of $2.2 billion and accounted for more than half of its diagnostic unit's revenue.
Published 20 Apr, 2021 06:12pm
Markets

BOARD MEETINGS

KARACHI: Board Meetings of Companies listed on the Pakistan Stock Exchange....
Published 14 Apr, 2021 03:21am
Markets

BOARD MEETINGS

KARACHI: Board Meetings of Companies listed on the Pakistan Stock Exchange....
Published 10 Apr, 2021 04:35am
Abbott profits soar
BR Research

Abbott profits soar

One good news out of 2020 has been the performance of the pharmaceutical sector. Players across the industry posted...
Published 10 Mar, 2021 07:40am